Carbamate Prodrug Concept for Hydroxamate HDAC Inhibitors

Ricky W. Johnstone, Histone-deacetylase inhibitors: novel drugs for the treatment of cancer Nature Reviews Drug Discovery. ,vol. 1, pp. 287- 299 ,(2002) , 10.1038/NRD772

Brian J North, Brett L Marshall, Margie T Borra, John M Denu, Eric Verdin, The Human Sir2 Ortholog, SIRT2, Is an NAD+-Dependent Tubulin Deacetylase Molecular Cell. ,vol. 11, pp. 437- 444 ,(2003) , 10.1016/S1097-2765(03)00038-8

Marielle Paris, Marina Porcelloni, Monica Binaschi, Daniela Fattori, Histone Deacetylase Inhibitors: From Bench to Clinic Journal of Medicinal Chemistry. ,vol. 51, pp. 1505- 1529 ,(2008) , 10.1021/JM7011408

David A. DeGoey, David J. Grampovnik, Charles A. Flentge, William J. Flosi, Hui-ju Chen, Clinton M. Yeung, John T. Randolph, Larry L. Klein, Tatyana Dekhtyar, Lynn Colletti, Kennan C. Marsh, Vincent Stoll, Mulugeta Mamo, David C. Morfitt, Bach Nguyen, James M. Schmidt, Sue J. Swanson, Hongmei Mo, Warren M. Kati, Akhteruzzaman Molla, Dale J. Kempf, 2-Pyridyl P1'-substituted symmetry-based human immunodeficiency virus protease inhibitors (A-792611 and A-790742) with potential for convenient dosing and reduced side effects. Journal of Medicinal Chemistry. ,vol. 52, pp. 2571- 2586 ,(2009) , 10.1021/JM900044W

Antonello Mai, Silvio Massa, Riccardo Pezzi, Silvia Simeoni, Dante Rotili, Angela Nebbioso, Annamaria Scognamiglio, Lucia Altucci, Peter Loidl, Gerald Brosch, Class II (IIa)-selective histone deacetylase inhibitors. 1. Synthesis and biological evaluation of novel (aryloxopropenyl)pyrrolyl hydroxyamides. Journal of Medicinal Chemistry. ,vol. 48, pp. 3344- 3353 ,(2005) , 10.1021/JM049002A

Steven G. Gray, Tomas J. Ekström, The human histone deacetylase family. Experimental Cell Research. ,vol. 262, pp. 75- 83 ,(2001) , 10.1006/EXCR.2000.5080

Markus Biel, Veit Wascholowski, Athanassios Giannis, Epigenetik – ein Epizentrum der Genregulation: Histone und histonmodifizierende Enzyme Angewandte Chemie. ,vol. 117, pp. 3248- 3280 ,(2005) , 10.1002/ANGE.200461346

Stefan Schäfer, Laura Saunders, Elena Eliseeva, Alfredo Velena, Mira Jung, Andreas Schwienhorst, Anja Strasser, Achim Dickmanns, Ralf Ficner, Sonja Schlimme, Wolfgang Sippl, Eric Verdin, Manfred Jung, Phenylalanine-containing hydroxamic acids as selective inhibitors of class IIb histone deacetylases (HDACs). Bioorganic & Medicinal Chemistry. ,vol. 16, pp. 2011- 2033 ,(2008) , 10.1016/J.BMC.2007.10.092

K. Hoffmann, M. Jung, G. Brosch, P. Loidl, A non-isotopic assay for histone deacetylase activity Nucleic Acids Research. ,vol. 27, pp. 2057- 2058 ,(1999) , 10.1093/NAR/27.9.2057

Steve Price, Walter Bordogna, Ruth Braganza, Richard J. Bull, Hazel J. Dyke, Sophie Gardan, Matthew Gill, Neil V. Harris, Robert A. Heald, Marco van den Heuvel, Peter M. Lockey, Julia Lloyd, Aranzazu G. Molina, Alan G. Roach, Fabien Roussel, Jonathan M. Sutton, Anne B. White, Identification and optimisation of a series of substituted 5-pyridin-2-yl-thiophene-2-hydroxamic acids as potent histone deacetylase (HDAC) inhibitors. Bioorganic & Medicinal Chemistry Letters. ,vol. 17, pp. 363- 369 ,(2007) , 10.1016/J.BMCL.2006.10.045